Navigation Links
Cell Therapeutics, Inc. (CTI) to Report 2008 First Quarter and Financial Results on May 8
Date:5/5/2008

SEATTLE, May 5 /PRNewswire-FirstCall/ -- On Thursday, May 8, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC; MTA) management team will host a quarterly conference call to discuss the company's 2008 first quarter achievements and financial results.

Conference Call Numbers

Thursday, May 8

8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time

1-877-835-3295 (US Participants)

1-303-262-2137 (International)

Call-back numbers for post-listening available at 11:30 a.m. Eastern:

1-800-405-2236 (US Participants)

1-303-590-3000 (International)

Passcode: 11114025#

Live audio webcast at http://www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.

Media Contact:

Cell Therapeutics, Inc.

Dan Eramian

T: 206.272.4343

C: 206.854.1200

Lindsey Jesch

T: 206.272.4347

F: 206.272.4434

E: media@ctiseattle.com

http://www.celltherapeutics.com/media.htm

Investors Contact:

Cell Therapeutics, Inc.

Leah Grant

T: 206.282.7100

F: 206.272.4434

E: invest@ctiseattle.com

http://www.celltherapeutics.com/investors.htm


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies ... technologies, today announced that their third Phase ... reduction of recurrence of hypertrophic scars following ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:7/30/2014)... 2014 Vala Sciences was recently ... Protection Agency (EPA). This new contract was awarded ... including tests designed to assess the effect of ... of connections between neurons (synapses), which are critical ... formation by environmental pollutants likely contributes to a ...
(Date:7/30/2014)... LayerBio, Inc., an MIT spinoff developing novel ... of seed financing from friends and family investors. Proceeds ... a novel sustained-release product for ophthalmology. , "We are ... commitment to this important work," said Dr. Ken Mandell, ... many areas in which innovations in drug delivery have ...
(Date:7/29/2014)... have hurdled a number of significant technological challenges ... observing technology originally created for the James Webb ... Investigator Harvey Moseley, a scientist at NASA,s Goddard ... that electrostatically actuated microshutter arrays that is, ... are as functional as the current technology,s magnetically ...
Breaking Biology Technology:RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4
... 25 Experts from PAREXEL,International Corporation (Nasdaq: ... provider, will present on key topics at ... in Barcelona,Spain being held March 3 - ... some of PAREXEL,s thought leaders, selected by ...
... to be presented at two international scientific ... ... ESBATech AG, a leading,developer of antibody fragment therapeutics, today announced ... segments of,the eye with topical delivery via eye drops. These data ...
... only 9 percent of Californias Mojave Desert could ... if the energy could be efficiently harvested, according ... are too expensive and inefficient for wide-scale commercial ... has developed a new anode coating strategy that ...
Cached Biology Technology:PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting 2PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting 3PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting 4ESBATech's Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 2ESBATech's Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3Special coating greatly improves solar cell performance 2
(Date:7/29/2014)... easier method to create DNAprotein conjugates. The method ... diseases. , DNA linked to proteins including ... be used in diagnostic techniques, nanotechnology and other ... DNA can be used for purposes such ... material. The method also provides easier access to ...
(Date:7/29/2014)... babies latest research from the University of Adelaide ... brains of many preterm children can perform almost as well ... the University,s Robinson Research Institute has found that ... in early life, their cognitive abilities as a teenager can ... the results of the study, published in this month,s issue ...
(Date:7/28/2014)... drugs already approved by the U.S. Food and Drug ... growth of certain bacterial pathogens inside human cells, including ... fever. The findings, published in mBio , the ... demonstrate a new way of identifying non-antibiotic drugs that ... A handful of drugs on the list inhibit the ...
Breaking Biology News(10 mins):New method provides researchers with efficient tool for tagging proteins 2Preterm children's brains can catch up years later 2New route to identify drugs that can fight bacterial infections 2
... When one fish gets injured, the rest of the school ... as "Schreckstoff" (meaning "scary stuff" in German). Now, researchers reporting online ... have figured out what that scary stuff is really made ... of sugar found in abundance in fish skin. When a fish ...
... have a wide variety of chips, colorful candies and bottles ... wrapped in pretty packages in these locations, what they usually ... dairy products necessary for a healthy diet. These ... Americans living in what are called food deserts, because they ...
... 10 years ago, deciphering the genetic information from one individual in ... would have been written off as science fiction. It was ... armies of sequencing robots working around the clock for almost a ... referred to as the genome by churning out the ...
Cached Biology News:For fish, fear smells like sugar 2Healthy foods missing from stores in low-income black neighborhoods, UGA study finds 2Healthy foods missing from stores in low-income black neighborhoods, UGA study finds 3Healthy foods missing from stores in low-income black neighborhoods, UGA study finds 4Genome sequencing finds unknown cause of epilepsy 2Genome sequencing finds unknown cause of epilepsy 3Genome sequencing finds unknown cause of epilepsy 4Genome sequencing finds unknown cause of epilepsy 5
... lines in combination with the corresponding optimized ... are only functional in combination with the ... transfected with this kit. The corresponding efficiencies ... percent (Efficiency [%] / viability [%]). ...
... Human Pathogenic Viruses The National ... preserves well characterised, authenticated human ... facility, and NCPV is able ... nucleic acids derived from them, ...
B-FABP (FL-132)...
... (rEK) is a highly purified preparation of ... serine protease which recognizes the identical cleavage ... has similar enzymatic activity (1). Novagen&'s enzyme ... to yield the highest activity available, and ...
Biology Products: